CM Care Tablet 10mg (Solipecan Sodium Succinate)

Adult dose

The usual recommended dose for adults (including elderly patients) is 5mg once daily. If necessary, the dose may be increased to a maximum of 10mg once daily. This medicine may be taken with or without food and should be swallowed whole with water. Dosage adjustment is required for the following patients. 1. Patients with renal impairment No dose adjustment is required for patients with mild or moderate renal impairment (creatinine clearance>30ml/min). In patients with severe renal impairment (creatinine clearance≤30ml/min), administer with caution and do not exceed 5mg once daily. 2. Patients with hepatic impairment No dose adjustment is required for patients with mild hepatic impairment. In patients with moderate hepatic impairment (Child-Pugh Class B), administer with caution and do not exceed 5mg once daily. 3. Patients receiving potent cytochrome P450 3A4 (CYP3A4) inhibitors In patients receiving ketoconazole or another potent CYP3A4 inhibitor (e.g., ritonavir, nelfinavir, itraconazole), limit the maximum daily dose to 5mg.

This medication should not be used in certain patients. For example, patients with urinary retention, severe gastrointestinal issues, myasthenia gravis, glaucoma, allergic to this drug or its components, patients undergoing hemodialysis, and those with severe liver or kidney dysfunction may face risks when taking this medication. Additionally, some patients should use this medication carefully. Patients at risk of urinary obstruction or with gastrointestinal obstruction or reduced motility, those with moderate to severe kidney or liver dysfunction, patients taking strong CYP3A4 enzyme inhibitors, those with gastroesophageal reflux or esophagitis, and patients with autonomic nervous system issues should be cautious when using this medication. Taking this medication may cause side effects such as dry mouth, constipation, or blurred vision. In particular, dry mouth and constipation occur more frequently at higher doses. Rarely, severe bowel obstruction, angioedema, or allergic reactions may occur, so if symptoms are severe, you should inform a doctor immediately. This drug may affect heart rhythm, so patients with heart disease or electrolyte imbalances should be cautious. Additionally, while taking this medication, the risk of accidents due to drowsiness or blurred vision while driving or operating machinery may increase, so one should be careful. Taking this medication with other anticholinergic drugs may enhance its effects or worsen side effects, so you must inform your healthcare provider of any medications you are taking. This drug is metabolized by certain enzymes in the liver (CYP3A4), so if taken with drugs that inhibit these enzymes, the dosage should be reduced, and patients with severe kidney or liver dysfunction should avoid taking such drugs together. For pregnant women, the safety of this medication has not been established, so caution should be exercised when taking it. Breastfeeding women should avoid this medication as it may be transmitted to the baby through breast milk. The safety and efficacy of this medication have not been confirmed for children and should not be used in this population. In case of overdose, symptoms such as headache, dizziness, drowsiness, and blurred vision may appear, and immediate treatment at a medical institution is necessary. Treatment may be required to reduce drug absorption in cases of overdose, and in severe cases, specialized treatment may be needed.

• Dry mouth
• constipation
• blurred vision
• urinary retention
• dry eyes
• fecal impaction
• colonic obstruction
• intestinal obstruction
• angioedema
• nausea

This medication should be stored in a tightly sealed container to protect it from air and moisture. The appropriate storage temperature is room temperature between 1°C and 30°C. Avoid storing it in excessively hot or cold places.

Appearance

Bright pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle